We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.01B
AUM Growth
-$40.3M
Cap. Flow
-$81.7M
Cap. Flow %
-8.12%
Top 10 Hldgs %
53.94%
Holding
5,392
New
831
Increased
1,118
Reduced
1,635
Closed
1,628

Sector Composition

Rank Sector Weight
1 Financials 3.27%
2 Industrials 2.61%
3 Consumer Discretionary 2.36%
4 Materials 2.25%
5 Technology 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLY
2776
DELISTED
Fly Leasing Limited
FLY
$4K ﹤0.01%
348
-152
-30% -$1.75K
DXGE
2777
DELISTED
WisdomTree Germany Hedged Equity Fund
DXGE
$4K ﹤0.01%
+155
New +$3.99K
UBOH
2778
DELISTED
United Bancshares Inc/OH
UBOH
$4K ﹤0.01%
188
-658
-78% -$12.7K
BDSI
2779
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$4K ﹤0.01%
+1,299
New +$3.3K
JPNL
2780
DELISTED
Direxion Daily Japan Bull 3x Shares
JPNL
$4K ﹤0.01%
+91
New +$3.83K
WBID
2781
DELISTED
WBI BullBear Quality 2000 ETF
WBID
$4K ﹤0.01%
+200
New +$4.21K
ATTU
2782
DELISTED
Attunity Ltd
ATTU
$4K ﹤0.01%
616
+116
+23% +$996
EMI
2783
DELISTED
Eaton Vance Michigan Municipal Income Trust
EMI
$4K ﹤0.01%
301
WMLP
2784
DELISTED
Westmoreland Resrc Partners, L.P
WMLP
$4K ﹤0.01%
778
+100
+15% +$562
CHOC
2785
DELISTED
iPath Pure Beta Cocoa ETN
CHOC
$4K ﹤0.01%
+100
New +$4.37K
FCH
2786
DELISTED
Felcor Lodging Trust
FCH
$4K ﹤0.01%
615
-6,314
-91% -$41.2K
DSCI
2787
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$4K ﹤0.01%
841
+513
+156% +$2.39K
RPTP
2788
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$4K ﹤0.01%
+447
New +$3.18K
EMSO
2789
DELISTED
EGSHARES EM STRATEGIC OPPORTUNITIES ETF
EMSO
$4K ﹤0.01%
+200
New +$3.8K
XLBS
2790
DELISTED
POWERSHARES S&P SMALLCAP MATERIALS PORT
XLBS
$4K ﹤0.01%
+100
New +$4K
BSQR
2791
DELISTED
BSQUARE Corporation
BSQR
$4K ﹤0.01%
779
+505
+184% +$2.53K
LENS
2792
DELISTED
Presbia PLC Ordinary Shares
LENS
$4K ﹤0.01%
796
+372
+88% +$1.75K
AACG
2793
ATA Creativity
AACG
$37.2M
$3K ﹤0.01%
754
AAON icon
2794
Aaon
AAON
$7.77B
$3K ﹤0.01%
150
-858
-85% -$15.8K
AEMD icon
2795
Aethlon Medical
AEMD
$1.66M
0
AFB
2796
AllianceBernstein National Municipal Income Fund
AFB
$317M
$3K ﹤0.01%
+225
New +$3.33K
AGEN
2797
Agenus
AGEN
$290M
$3K ﹤0.01%
20
-312
-94% -$35.8K
AGRO icon
2798
Adecoagro
AGRO
$1.36B
$3K ﹤0.01%
300
-2,592
-90% -$27.4K
ANIX icon
2799
Anixa Biosciences
ANIX
$116M
$3K ﹤0.01%
800
-177
-18% -$590
YDKG
2800
Yueda Digital Holding
YDKG
$5.97M
0

Similar funds

Tower Research Capital (TRC)'s Q3 2016 Portfolio in Review

As of Q3 2016, Tower Research Capital (TRC) held 5,392 positions worth $1.01B, down 3.8% from $1.05B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $81.7M in Q3 2016, closing 1,628 positions and reducing 1,635 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.3% of assets, down from 6.1% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.7M.

  • Tower Research Capital (TRC)'s largest Q3 2016 buy was Vanguard S&P 500 ETF: 74,203 shares worth $14.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $303M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2016 reduction was State Street Consumer Discretionary Select Sector SPDR ETF, cutting an estimated $24.2M.
  • Tower Research Capital (TRC) fully exited iShares Biotechnology ETF in Q3 2016, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $1.01B portfolio in Q3 2016.
  • Tower Research Capital (TRC) opened 831 new positions and closed 1,628 in Q3 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 3.8% quarter-over-quarter to $1.01B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.